Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARD
3401
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $1.49M | ﹤0.01% |
60,873
-6,348
| -9% | -$164K |
|
|
OTLY
3402
Oatly Group
OTLY
$465M
| $1.49M | ﹤0.01% |
+3,038
| New | +$1.51M |
|
|
LSEA
3403
DELISTED
Landsea Homes
LSEA
| $1.48M | ﹤0.01% |
177,005
+66,842
| +61% | +$608K |
|
|
NH
3404
DELISTED
NantHealth, Inc
NH
| $1.48M | ﹤0.01% |
42,457
+1,341
| +3% | +$53.3K |
|
3405
Stratus Properties
STRS
$156M
| $1.48M | ﹤0.01% |
59,835
-34,300
| -36% | -$987K |
|
3406
Comstock
LODE
$208M
| $1.47M | ﹤0.01% |
40,574
-24,354
| -38% | -$939K |
|
|
LABP
3407
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $1.47M | ﹤0.01% |
12,752
+1,696
| +15% | +$189K |
|
|
CTIC
3408
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.47M | ﹤0.01% |
589,150
+106,502
| +22% | +$255K |
|
|
MARK
3409
DELISTED
Remark Holdings, Inc.
MARK
| $1.46M | ﹤0.01% |
78,742
+844
| +1% | +$15.8K |
|
|
SCPX
3410
DELISTED
Scorpius Holdings, Inc.
SCPX
| $1.46M | ﹤0.01% |
54
+6
| +13% | +$163K |
|
3411
Orion Energy Systems
OESX
$41M
| $1.46M | ﹤0.01% |
25,491
-19,965
| -44% | -$1.21M |
|
|
ICBK
3412
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $1.46M | ﹤0.01% |
42,881
-32,057
| -43% | -$807K |
|
3413
Eastern Company
EML
$143M
| $1.45M | ﹤0.01% |
47,930
-31,008
| -39% | -$925K |
|
|
ABST
3414
DELISTED
Absolute Software Corp
ABST
| $1.45M | ﹤0.01% |
85,589
+10,269
| +14% | +$146K |
|
3415
Talphera
TLPH
$66.4M
| $1.45M | ﹤0.01% |
52,540
-31,038
| -37% | -$831K |
|
|
PMBC
3416
DELISTED
Pacific Mercantile Bancorp
PMBC
| $1.45M | ﹤0.01% |
168,609
+18,154
| +12% | +$158K |
|
3417
Energy Transfer Partners
ET
$70.1B
| $1.45M | ﹤0.01% |
136,389
+20,361
| +18% | +$195K |
|
3418
Chemung Financial Corp
CHMG
$393M
| $1.45M | ﹤0.01% |
32,666
-21,249
| -39% | -$928K |
|
|
CALA
3419
DELISTED
Calithera Biosciences, Inc
CALA
| $1.45M | ﹤0.01% |
34,588
-22,974
| -40% | -$1.01M |
|
|
CKPT
3420
DELISTED
Checkpoint Therapeutics
CKPT
| $1.44M | ﹤0.01% |
48,941
-30,914
| -39% | -$857K |
|
|
BBQ
3421
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $1.44M | ﹤0.01% |
75,983
+42,220
| +125% | +$562K |
|
|
SPRB
3422
Spruce Biosciences
SPRB
$118M
| $1.44M | ﹤0.01% |
1,714
+253
| +17% | +$270K |
|
3423
Gyre Therapeutics
GYRE
$641M
| $1.44M | ﹤0.01% |
44,331
-26,919
| -38% | -$924K |
|
3424
National Grid
NGG
$80.4B
| $1.44M | ﹤0.01% |
25,449
+3,308
| +15% | +$188K |
|
|
SGTX
3425
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $1.44M | ﹤0.01% |
10,290
+910
| +10% | +$160K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.